Article
An optimized “hypoxia in a pill” regimen reverses neurodegenerative disease phenotypes in multiple preclinical models
2026-07-03
Abstract excerpt
A growing body of pre-clinical research has demonstrated the therapeutic potential of chronic, continuous hypoxia (11% FIO2) for treating both rare and common forms of neurodegeneration (1). However, the chronic delivery of hypoxic gas poses both practical challenges and long-term safety concerns. We previously introduced a small molecule, “hypoxia-in-a-pill” regimen that combines the hemoglobin affinity enhancer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 55cd54d3-c419-5042-bbd7-b3a594c8e50e
- DOI
- 10.64898/2026.06.30.734089
